VanWijk Marja J, VanBavel E, Sturk A, Nieuwland R
Department of Obstetrics and Gynaecology, Academic Medical Center, Amsterdam, The Netherlands.
Cardiovasc Res. 2003 Aug 1;59(2):277-87. doi: 10.1016/s0008-6363(03)00367-5.
Microparticles are membrane vesicles released from many different cell types. There are two mechanisms that can result in their formation, cell activation and apoptosis. In these two mechanisms, different pathways are involved in microparticle generation. Microparticle generation seems to be a well regulated process. Microparticles vary in size, phospholipid and protein composition. They have a potent pro-inflammatory effect, promote coagulation and affect vascular function. Since these processes are all involved in the pathogenesis of cardiovascular disease and circulating microparticle numbers are altered in many cardiovascular diseases, a role for microparticles in the pathogenesis of cardiovascular diseases is likely. Although hard evidence for a role of microparticles in cardiovascular diseases at present is still only limited, new evidence is accumulating rapidly to support this theory. Elucidation of the microparticle composition and the mechanisms involved in exertion of their effects will supply this evidence and enable us to develop additional intervention strategies for prevention and treatment of cardiovascular diseases.
微粒是从多种不同细胞类型释放出来的膜泡。有两种机制可导致其形成,即细胞活化和细胞凋亡。在这两种机制中,微粒生成涉及不同的途径。微粒生成似乎是一个受到良好调控的过程。微粒在大小、磷脂和蛋白质组成方面存在差异。它们具有强大的促炎作用,促进凝血并影响血管功能。由于这些过程均参与心血管疾病的发病机制,且在许多心血管疾病中循环微粒数量会发生改变,因此微粒在心血管疾病发病机制中可能发挥作用。尽管目前关于微粒在心血管疾病中作用的确凿证据仍然有限,但新的证据正在迅速积累以支持这一理论。阐明微粒组成及其发挥作用所涉及的机制将提供这一证据,并使我们能够开发出更多用于预防和治疗心血管疾病的干预策略。